PharmaCann has filed a notice of an exempt offering of securities to raise $9,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, PharmaCann is raising $9,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brett Novey played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About PharmaCann
PharmaCann, founded in 2014, is one of the countrys largest vertically integrated cannabis companies, providing safe, reliable, top-quality cannabis products to improve peoples lives. By investing in people, practices and infrastructure, we are shaping a new, vital, wellness-focused industry. Our goal is to increase sustainable access to cannabis by offering effective, affordable and trusted products and services. We are licensed in eight states to grow, process and/or dispense medicinal cannabis products for adult and pediatric patients, as well as for responsible adult use. We are expanding rapidly but steadily as we continue to earn new state licenses and gain recognition as a trusted resource in this evolving space. We invest in best practices at every turn to ensure people have access to the most effective options for feeling and living better. We are constantly researching and developing new forms and formulations of cannabinoid-based treatments to improve peoples well-being and help them live their best lives.
To learn more about PharmaCann, visit http://www.pharmacannis.com/
Contact:
Brett Novey, Chief Executive Officer
312-667-6260
https://www.linkedin.com/in/brett-n-37258a4/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.